Keyphrases
Aggressive Therapy
100%
Aggressive Tumor
20%
Anti-metastatic Agent
6%
Anticancer
13%
Biochemist
13%
Biomedical Engineer
20%
Blood Vessel System
20%
Cancer Cell Populations
20%
Cancer Patients
6%
Cancer Stem Cell Therapy
20%
Cancer Stem Cells
13%
Cell Generation
20%
Cell Motility
13%
Cell Population
26%
Circulating Cells
20%
Circulating Tumor Cells
26%
Circulatory System
26%
Collaborative Ventures
13%
Culture Conditions
13%
Curative Treatment
20%
Cycling Hypoxia
13%
Cytotoxic Agents
6%
Drug-resistant Tumor
100%
Early Detection
13%
Epithelial-mesenchymal Transition
20%
Hypoxia
6%
In Vitro Device
20%
In Vitro Model
6%
In Vitro System
13%
Intermittent Hypoxia
20%
Lymphatic System
13%
Metastasizing
20%
Metastatic Cancer
40%
Metastatic Cells
13%
Microenvironment
13%
Migrating Cells
20%
Motile Cells
20%
Multiplexing
13%
New Targets
6%
On-a-chip
100%
Oxygen Atmosphere
20%
Oxygen-rich
20%
Pancreatic Cancer
6%
Pancreatic Cancer Stem Cells
20%
Pancreatic Ductal Adenocarcinoma
66%
Pancreatic Tumor
6%
Patient Outcomes
6%
Patient Samples
13%
Primary Tumor Site
20%
Public Health
6%
Secondary Oxygen
20%
Secondary Site
20%
Shock
13%
Stem Cells
26%
Surgical Resection
13%
Targets for Therapy
20%
Therapeutic Targeting
13%
Therapy Development
20%
Therapy Resistance
20%
Therapy-resistant
100%
Treatment Outcome
6%
Tumor
26%
Tumor Blood Vessels
13%
Tumor Cells
66%
Tumor Compartments
13%
Tumor Hypoxia
6%
Tumor Metastasis
6%
Viable Cells
13%
Medicine and Dentistry
Antimetastatic Agent
6%
Biological Marker
6%
Cancer Stem Cell
26%
Cell Motility
13%
Cell Population
40%
Circulating Tumor Cell
40%
Circulatory System
26%
Cytotoxic Agent
6%
Disease
13%
Hypoxia
20%
In Vitro
33%
Intermittent Hypoxia
20%
Lymphatic System
13%
Malignant Neoplasm
20%
Mesenchymal-Epithelial Transition
13%
Metastatic Carcinoma
46%
Neoplasm
40%
Pancreas Adenocarcinoma
66%
Pancreas Cancer
6%
Pancreas Tumor
6%
Pancreatic Cancer Stem Cell
20%
Primary Tumor
13%
Shock (Circulatory)
13%
Stem Cell
26%
Stem Cell Therapy
13%
Surgery
13%
Therapy Development
20%
Therapy Resistance
20%
Tumor Cell
66%
Tumor Hypoxia
6%
Vascular Tissue Neoplasm
13%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
10%
Hypoxia
19%
Intermittent Hypoxia
15%
Malignant Neoplasm
46%
Metastasis
30%
Neoplasm
66%
Pancreas Adenocarcinoma
66%
Pancreas Cancer
15%
Primary Tumor
10%
Therapy Resistance
15%
Vascular Tumor
10%